HRSA data · VICP as of 1 October 2026 · CICP tables dated 8 October 2026
Vaccine injury compensation statistics (VICP and CICP)
Petitions filed, compensated and dismissed, and amounts paid, by vaccine and by fiscal year, from the Health Resources and Services Administration's published reports, in sortable tables.
VICP outcomes by vaccine, petitions filed 2006–2024
Vaccine listed first in the petition (others may also be alleged). Click a column to sort. 11,248 compensated petitions against 5.65 billion doses distributed is about 2.0 per million doses; HRSA's report text says approximately 1 per million. Rates are shown only for vaccines with at least 10 million doses distributed; smaller counts swing too much to compare, and rates also reflect who files petitions, not only how often injuries occur.
| Vaccine | Doses distributed (CDC) | Concession | Court decision | Settlement | Compensable | Dismissed | Compensable per million doses |
|---|---|---|---|---|---|---|---|
| DT | 794,777 | 1 | 0 | 5 | 6 | 4 | too few doses |
| DTaP | 129,682,700 | 36 | 25 | 133 | 194 | 158 | 1.50 |
| DTaP-Hep B-IPV | 102,101,782 | 10 | 8 | 38 | 56 | 77 | 0.55 |
| DTaP-HIB | 1,135,474 | 0 | 2 | 2 | 4 | 2 | too few doses |
| DTaP-IPV | 47,563,529 | 1 | 0 | 7 | 8 | 5 | 0.17 |
| DTaP-IPV-HIB | 96,295,911 | 5 | 5 | 11 | 21 | 47 | 0.22 |
| DtaP-IPV-HIB-Hep B | 7,038,594 | 0 | 0 | 0 | 0 | 2 | too few doses |
| DTP | 0 | 1 | 1 | 3 | 5 | 5 | too few doses |
| DTP-HIB | 0 | 1 | 0 | 2 | 3 | 1 | too few doses |
| Hep A-Hep B | 21,957,724 | 6 | 2 | 23 | 31 | 12 | 1.41 |
| Hepatitis A (Hep A) | 250,400,774 | 20 | 6 | 63 | 89 | 53 | 0.36 |
| Hepatitis B (Hep B) | 270,766,553 | 25 | 13 | 104 | 142 | 125 | 0.52 |
| Hep B-HIB | 4,787,457 | 1 | 1 | 2 | 4 | 1 | too few doses |
| HIB | 172,182,073 | 4 | 2 | 13 | 19 | 14 | 0.11 |
| HPV | 177,457,602 | 67 | 19 | 144 | 230 | 671 | 1.30 |
| Influenza | 2,714,400,000 | 3,230 | 375 | 4,819 | 8,424 | 1,427 | 3.10 |
| IPV | 91,622,882 | 0 | 2 | 5 | 7 | 6 | 0.08 |
| Measles | 135,660 | 1 | 0 | 2 | 3 | 0 | too few doses |
| Meningococcal | 177,573,215 | 31 | 7 | 61 | 99 | 37 | 0.56 |
| MMR | 146,684,769 | 38 | 16 | 116 | 170 | 182 | 1.16 |
| MMR-Varicella | 50,474,023 | 14 | 1 | 16 | 31 | 29 | 0.61 |
| MR | 0 | 0 | 0 | 0 | 0 | 0 | too few doses |
| Mumps | 110,749 | 0 | 0 | 0 | 0 | 0 | too few doses |
| OPV | 0 | 1 | 0 | 0 | 1 | 5 | too few doses |
| Pertussis | 0 | 0 | 0 | 0 | 0 | 0 | too few doses |
| Pneumococcal Conjugate | 371,374,550 | 87 | 18 | 119 | 224 | 122 | 0.60 |
| Rotavirus | 167,131,097 | 38 | 4 | 27 | 69 | 27 | 0.41 |
| Rubella | 422,548 | 0 | 1 | 1 | 2 | 0 | too few doses |
| Td | 83,871,193 | 30 | 6 | 82 | 118 | 31 | 1.41 |
| Tdap | 406,747,693 | 391 | 37 | 642 | 1,070 | 230 | 2.63 |
| Tetanus | 3,836,052 | 47 | 5 | 91 | 143 | 28 | too few doses |
| Unqualified Vaccine | 0 | 0 | 0 | 3 | 3 | 65 | too few doses |
| Unspecified | 0 | 2 | 1 | 5 | 8 | 598 | too few doses |
| Varicella | 155,446,100 | 15 | 7 | 42 | 64 | 33 | 0.41 |
VICP petitions by vaccine since 1988
10/01/1988 through 2026-10-01. "Unspecified" petitions were filed with too little information to make a determination.
| Vaccine | Filed: injury | Filed: death | Filed: total | Compensated | Dismissed |
|---|---|---|---|---|---|
| DT | 69 | 9 | 78 | 26 | 52 |
| DTaP | 529 | 91 | 620 | 276 | 297 |
| DTaP-Hep B-IPV | 107 | 42 | 149 | 57 | 78 |
| DTaP-HIB | 13 | 1 | 14 | 8 | 4 |
| DTaP-IPV | 18 | 0 | 18 | 8 | 5 |
| DTaP-IPV-HIB | 55 | 22 | 77 | 21 | 47 |
| DtaP-IPV-HIB-Hep B | 10 | 3 | 13 | 0 | 2 |
| DTP | 3,287 | 699 | 3,986 | 1,274 | 2,711 |
| DTP-HIB | 20 | 8 | 28 | 7 | 21 |
| Hep A-Hep B | 55 | 0 | 55 | 31 | 13 |
| Hepatitis A (Hep A) | 164 | 9 | 173 | 89 | 55 |
| Hepatitis B (Hep B) | 811 | 63 | 874 | 334 | 473 |
| Hep B-HIB | 10 | 0 | 10 | 5 | 3 |
| HIB | 51 | 3 | 54 | 26 | 24 |
| HPV | 1,033 | 24 | 1,057 | 230 | 671 |
| Influenza | 11,759 | 266 | 12,025 | 8,442 | 1,430 |
| IPV | 270 | 14 | 284 | 11 | 272 |
| Measles | 145 | 19 | 164 | 58 | 106 |
| Meningococcal | 175 | 3 | 178 | 99 | 37 |
| MMR | 1,086 | 66 | 1,152 | 453 | 642 |
| MMR-Varicella | 72 | 2 | 74 | 31 | 29 |
| MR | 15 | 0 | 15 | 6 | 9 |
| Mumps | 10 | 0 | 10 | 1 | 9 |
| OPV | 282 | 28 | 310 | 158 | 152 |
| Pertussis | 4 | 3 | 7 | 2 | 5 |
| Pneumococcal Conjugate | 540 | 26 | 566 | 228 | 136 |
| Rotavirus | 136 | 7 | 143 | 89 | 38 |
| Rubella | 190 | 4 | 194 | 71 | 123 |
| Td | 274 | 3 | 277 | 164 | 82 |
| Tdap | 1,702 | 10 | 1,712 | 1,069 | 230 |
| Tetanus | 268 | 3 | 271 | 166 | 55 |
| Unqualified Vaccine | 127 | 13 | 140 | 3 | 132 |
| Unspecified | 5,438 | 9 | 5,447 | 12 | 5,422 |
| Varicella | 135 | 12 | 147 | 84 | 45 |
VICP by fiscal year: filings, adjudications and payments
Petitions are usually adjudicated 2–3 years after filing, so a year's adjudications are not that year's filings. Attorneys' fees include fees paid on dismissed petitions and interim fees.
| Fiscal year | Petitions filed | Adjudicated compensable | Dismissed | Petitioner awards | Attorneys' fees and costs | Total outlays |
|---|---|---|---|---|---|---|
| FY 2026 | 1,192 | 976 | 191 | $148,280,255 | $65,020,414 | $213,300,669 |
| FY 2025 | 1,300 | 1,048 | 271 | $142,867,925 | $63,476,074 | $206,344,000 |
| FY 2024 | 1,185 | 1,132 | 307 | $149,653,344 | $53,473,887 | $203,127,231 |
| FY 2023 | 1,167 | 947 | 351 | $123,810,694 | $50,051,874 | $173,862,568 |
| FY 2022 | 1,029 | 939 | 289 | $195,693,890 | $34,226,343 | $229,920,232 |
| FY 2021 | 2,057 | 753 | 245 | $208,258,401 | $36,146,892 | $244,405,293 |
| FY 2020 | 1,192 | 718 | 232 | $186,860,678 | $31,163,529 | $218,024,206 |
| FY 2019 | 1,282 | 641 | 191 | $196,217,708 | $29,658,418 | $225,876,125 |
| FY 2018 | 1,238 | 518 | 179 | $199,588,007 | $26,879,993 | $226,468,000 |
| FY 2017 | 1,243 | 686 | 233 | $252,245,933 | $29,922,605 | $282,168,538 |
| FY 2016 | 1,120 | 729 | 179 | $230,140,251 | $22,458,609 | $252,598,860 |
| FY 2015 | 803 | 523 | 150 | $204,137,880 | $21,121,222 | $225,259,102 |
| FY 2014 | 633 | 370 | 187 | $202,084,196 | $21,479,450 | $223,563,646 |
| FY 2013 | 504 | 382 | 592 | $254,666,327 | $21,979,567 | $276,645,894 |
| FY 2012 | 402 | 261 | 2,286 | $160,589,710 | $23,153,744 | $183,743,454 |
| FY 2011 | 386 | 267 | 2,056 | $216,319,428 | $17,092,670 | $233,412,098 |
| FY 2010 | 447 | 180 | 321 | $179,387,341 | $9,874,098 | $189,261,440 |
| FY 2009 | 397 | 135 | 268 | $74,142,491 | $11,203,214 | $85,345,705 |
| FY 2008 | 417 | 141 | 146 | $75,716,552 | $7,840,430 | $83,556,982 |
| FY 2007 | 409 | 84 | 142 | $91,449,434 | $5,726,175 | $97,175,609 |
| FY 2006 | 325 | 73 | 193 | $48,746,163 | $3,794,832 | $52,540,994 |
| FY 2005 | 735 | 56 | 235 | $55,065,797 | $4,485,251 | $59,551,048 |
| FY 2004 | 1,214 | 64 | 244 | $61,933,764 | $4,277,945 | $66,211,709 |
| FY 2003 | 2,592 | 52 | 104 | $82,816,240 | $4,693,410 | $87,509,650 |
| FY 2002 | 958 | 88 | 86 | $59,799,604 | $3,309,844 | $63,109,448 |
| FY 2001 | 215 | 74 | 92 | $105,878,633 | $5,440,091 | $111,318,723 |
| FY 2000 | 163 | 125 | 106 | $125,945,196 | $5,836,820 | $131,782,016 |
| FY 1999 | 411 | 102 | 130 | $95,916,860 | $5,107,689 | $101,024,549 |
| FY 1998 | 120 | 121 | 180 | $127,543,313 | $5,941,040 | $133,484,353 |
| FY 1997 | 104 | 169 | 192 | $113,572,207 | $5,825,668 | $119,397,875 |
| FY 1996 | 84 | 169 | 411 | $100,425,325 | $5,459,500 | $105,884,825 |
| FY 1995 | 180 | 171 | 542 | $104,085,266 | $5,928,907 | $110,014,173 |
| FY 1994 | 107 | 194 | 461 | $98,151,900 | $6,737,707 | $104,889,607 |
| FY 1993 | 140 | 131 | 540 | $119,638,268 | $5,709,726 | $125,347,994 |
| FY 1992 | 189 | 164 | 534 | $94,538,071 | $4,214,605 | $98,752,676 |
| FY 1991 | 2,718 | 154 | 481 | $95,980,493 | $2,861,568 | $98,842,061 |
| FY 1990 | 1,492 | 97 | 43 | $53,252,510 | $1,436,705 | $54,689,216 |
| FY 1989 | 148 | 30 | 17 | $1,317,655 | $54,107 | $1,371,762 |
| FY 1988 | 24 | 0 | 0 | – | – | – |
CICP: COVID-19 and other countermeasure claims
COVID-19 vaccines are covered by the Countermeasures Injury Compensation Program, not the VICP. HRSA's tables (dated 8 October 2026) list 14,250 COVID-19 countermeasure claims filed, 11,218 of them naming a COVID-19 vaccine. 96 claims have been compensated across all countermeasures, $14,068,767 in total; 66 were for COVID-19 vaccines ($7,990,678). HRSA's printed total ($14,064,655.16) leaves out the last listed claim (no. 96, $4,112.05); the sum of all listed claims is used here.
| HRSA table | Claims | COVID-19 vaccine | Other countermeasures |
|---|---|---|---|
| 1. COVID-19 claims filed, by countermeasure and injury | 14,250 | 11,218 | 3,032 |
| 2. Non-COVID-19 countermeasure claims | 11 | 1 | 10 |
| 3. Pending compensation | 50 | 50 | 0 |
| 4. Claims compensated | 96 | 66 | 30 |
| 5. Eligible for compensation (HRSA table 5) | 14 | 4 | 10 |
| 6. Denied: required medical records not submitted | 3,723 | 2,754 | 969 |
| 7. Denied: standard of proof not met | 1,896 | 1,289 | 607 |
| 8. Ineligible: filing deadline missed | 2,770 | 2,667 | 103 |
| 9. Ineligible: product not a covered countermeasure | 156 | 3 | 153 |
| 10. Ineligible: no countermeasure alleged | 17 | 0 | 17 |
The split between COVID-19 vaccines and other countermeasures is this site's grouping of HRSA's free-text countermeasure field and may differ slightly from HRSA's own counts.
Common questions
How much has the Vaccine Injury Compensation Program paid?
According to HRSA's report updated 1 October 2026, VICP outlays from fiscal year 1989 through fiscal year 2026 total $5,699,782,331: $5,036,717,709 in awards to petitioners and $663,064,622 in attorneys' fees and costs.
Does compensation mean the vaccine caused the injury?
Not necessarily. HRSA states that about 60 percent of VICP compensation comes from negotiated settlements in which HHS has not concluded that the vaccine caused the injury (in the 2006–2024 table, 59% of compensated petitions were settlements). Compensation can also follow a concession by HHS or a court decision.
Are COVID-19 vaccines covered by the VICP?
No. COVID-19 vaccines are covered by the Countermeasures Injury Compensation Program (CICP). As of HRSA's tables dated 8 October 2026, 14,250 COVID-19 countermeasure claims had been filed and 96 claims had been compensated across all countermeasures (66 of them for COVID-19 vaccines).
How many people are compensated per million vaccine doses?
For petitions filed 2006–2024, 11,248 were compensated against 5.65 billion doses of covered vaccines distributed, about 2.0 per million doses. HRSA's report text says approximately 1 per million; distributed doses are not administered doses.
Which injuries and time windows the programs presume: Vaccine Injury Table and CICP table. Downloads: vicp_statistics.json · cicp_statistics.json.
Sources: HRSA VICP Monthly Statistics Report, updated 1 October 2026; HRSA CICP data tables. Not legal or medical advice.